The GPx activity was standardized to 300 units/liter
Common causes include: Reduced dietary intake People following vegan or strict vegetarian diets can be at higher risk if theyre not using B12-fortified foods or supplements

References The Lancet (2021) Onceweekly cagrilintide for weight management: phase 2 dosefinding trial (Lau et al.) Int J Mol Sci (2024) Amylin, another important neuroendocrine hormone for treatment of diabesity PMC (2022) Mediators of amylin action in metabolic control The Lancet (2021) Cagrilintide phase 2 trial: 10.8% weight loss at 4.5 mg dose over 26 weeks N Engl J Med (2025) REDEFINE 1: Coadministered cagrilintide and semaglutide in adults with overweight or obesity The Lancet (2021) Cagrilintide + semaglutide phase 1b trial: safety, tolerability, pharmacokinetics (Enebo et al.) J Med Chem (2021) Development of cagrilintide: a longacting amylin analogue Brain Res Rev (2005) Pancreatic amylin as a centrally acting satiating hormone PMC (2006) Pancreatic signals controlling food intake: insulin, glucagon, and amylin PMC (2016) Amylinmediated control of glycemia, energy balance, and cognition PMC (2024) Clinical pharmacokinetics of semaglutide: systematic review (includes cagrilintide PK data) N Engl J Med (2025) REDEFINE 2: Cagrilintidesemaglutide in adults with overweight/obesity and type 2 diabetes CDC Vaccine administration: subcutaneous injection technique and site guidance CDC (PDF) You Call the Shots: subcutaneous injection diagram and best practices Additional Research and Background These sources provide related context and are not presented as support for a specific statement above

Hims & Hers is mass marketing unapproved knock-off versions of Wegovy and Ozempic that evade the FDAs gold standard review processthats dangerous and deceptive to patients and undermines the scientific innovation and regulatory rigor in place to ensure these treatments are safe and effective
Exenatide Once Weekly Versus Placebo in Parkinsons Disease: A Randomised, Double-Blind, Placebo-Controlled Trial
Wegovy en pastillas, que contiene el mismo principio activo que las inyecciones, la semaglutida